Skip to main content

Table 4 Quality of life scores of SLE patients in control and therapy groups over time

From: Psychoanalytic psychotherapy improves quality of life, depression, anxiety and coping in patients with systemic lupus erythematosus: a controlled randomized clinical trial

Domain Time Control (n = 43) Therapy (n = 37) Inter-group P*
Median (Min-Max) Median (Min-Max)
Physical function T1 12.0 (6.0–34.0) 10.0 (2.0–39.0) 0.645
T2 14.0 (6.0–36.0) 9.0 (6.0–30.0) 0.023
Intra-group P** 0.245 0.057  
Occupational activity T1 24.0 (9.0–59.0) 25.0 (1.0–59.0) 0.743
T2 31.0 (9.0–61.0) 17.0 (9.0–42.0) 0.001
Intra-group P** 0.055 0.001  
Symptoms T1 22.0 (8.0–49.0) 23.0 (6.0–51.0) 0.589
T2 25.0 (8.0–46.0) 14.0 (8.0–37.0) 0.001
Intra-group P** 0.023 < 0.001  
Treatment T1 11.0 (4.0–22.0) 10.0 (3.0–19.0) 0.591
T2 11.0 (4.0–25.0) 8.0 (1.0–20.0) 0.002
Intra-group P** 0.093 0.008  
Humor T1 14.0 (4.0–28.0) 15.0 (4.0–28.0) 0.376
T2 13.0 (4.0–28.0) 9.0 (4.0–26.0) 0.005
Intra-group P** 0.321 < 0.001  
Self-Image T1 20.0 (9.0–51.0) 25.0 (9.0–53.0) 0.178
T2 20.0 (9.0–54.0) 15.0 (9.0–33.0) 0.003
Intra-group P** 0.764 < 0.001  
Total score T1 114.0 (40.0–204.0) 109.0 (44.0–226.0) 0.596
T2 113.0 (45.0–236.0) 71.0 (40.0–153.0) < 0.001
Intra-group P** 0.041   
  1. SLEQOL Systemic Lupus Erythematosus Quality of Life (Range: 40–280)
  2. *Mann-Whitney test; **Wilcoxon test
  3. P < 0.05 significant